POLYUNSATURATED FATTY ACIDS AND THEIR OXIDATION PRODUCTS
DOI:
https://doi.org/10.56782/pps.116Keywords:
polyunsaturated fatty acids (PUFA), essential fatty acids (EFA), free radical lipids peroxidation, isoprostanes, neuroprostanes, isofurans, neurofuransAbstract
Polyunsaturated fatty acids (PUFA) are indispensable for proper development and normal function of an organism. They are of particular significance in human nutrition. There are two major subgroups of PUFAs: ω–3 and ω–6. They play an important role in the treatment of atherosclerosis and other pathological states that are associated with disorders of lipid homeostasis. Certain PUFAs are precursors of biologically important compounds, such as prostaglandins, mono and dihydroxy fatty acids, iso– and neuroprostanes, as well as iso– and neurofurans. In recent years numerous reports concerning their potential role as biomarkers of pathological conditions have appeared.
Downloads
References
Jelińska M. Biul. Wydz. Farm WUM. 2005, 1, 1–9.
Nowak JZ. Farmakoter. w Psychiatrii Neurol. 2009, 127–146.
Nowak J. Postępy Hig. Med. Dośw. 2010, 64, 115–132.
Achremowicz K. Szary–Sworst K. Żywność. Nauka. Technol. Jakość. 2005, 3 (44), 23–35.
Socha P. Pediatr. Współczesna Gastroenterol. Żyw. Dziecka. 2001, 3, 29–32.
Pryor WA. Free Radic. Biol. Med. 1989, 7, 177–178. DOI: https://doi.org/10.1016/0891-5849(89)90010-5
Pryor WA. Free Radic. Biol. Med. 1999, 27, 1135–1136. DOI: https://doi.org/10.1016/S0891-5849(99)00213-0
Cracowski JL. Durand T. Bessard G. Trends Pharmacol. Sci. 2002, 23, 360–366. DOI: https://doi.org/10.1016/S0165-6147(02)02053-9
Farooqui T. Farooqui AA. Mech. Ageing Dev. 2009, 130, 203–215. DOI: https://doi.org/10.1016/j.mad.2008.11.006
Yin H. Xu L. Porter NA. Chem. Rev. 2011, 111, 5944–5972. DOI: https://doi.org/10.1021/cr200084z
Pryor WA. Free Radic. Biol. Med. 1989, 7, 229. DOI: https://doi.org/10.1016/0891-5849(89)90128-7
Jahn U. Galano JM. Durand T. Angew. Chem. Int. Ed. 2008, 47, 5894–5955. DOI: https://doi.org/10.1002/anie.200705122
Siddiqui RA. Harvey K. Stillwell W. Chem. Phys. Lipids. 2008, 153, 47–56. DOI: https://doi.org/10.1016/j.chemphyslip.2008.02.009
Gao L. Yin H. Milne GL. Porter V. Morrow JD. J. Biol. Chem. 2006, 281, 14092–14099. DOI: https://doi.org/10.1074/jbc.M601035200
Milne GL. Yin H. Hardy KD. Davies SS. Roberts LJ. Chem. Rev. 2011, 111, 5973–5996. DOI: https://doi.org/10.1021/cr200160h
Roberts LJ. Fessel JP. Davies SS. Brain Pathol. 2005, 15, 143–148. DOI: https://doi.org/10.1111/j.1750-3639.2005.tb00511.x
Morrow JD. Hill KE. Burk RF. Nammour TM. Badr KF. Roberts LJ. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 9383–9387. DOI: https://doi.org/10.1073/pnas.87.23.9383
Roberts II LJ. Morrow JD. Free Radic. Biol. Med. 2000, 28, 505–513. DOI: https://doi.org/10.1016/S0891-5849(99)00264-6
Roberts II LJ. Fessel JP. Chem. Phys. Lipids. 2004, 128, 173–186. DOI: https://doi.org/10.1016/j.chemphyslip.2003.09.016
Nikolaidis MG. Kyparos A. Vrabas IS. Prog. Lipid Res. 50 (2011) 89–103. DOI: https://doi.org/10.1016/j.plipres.2010.10.002
Praticò D. Clark CM. Lee VMY. Trojanowski JQ. Rokach J. FitzGerald GA. Ann. Neurol. 2000, 48, 809–812. DOI: https://doi.org/10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9
Montine TJ. Neely MD. Quinn JF. Beal MF. Markesbery WR. Roberts II LJ. Morrow JD. Free Radic. Biol. Med. 2002, 33, 620–626. DOI: https://doi.org/10.1016/S0891-5849(02)00807-9
Galano JM. Mas E. Barden A. Mori TA. Signorini C. De Felice C. Barrett A. Opere C. Pinot E. Schwedhelm E. Benndorf R. Roy J. Le Guennec JY. Oger C. Durand T. Prostaglandins Other Lipid Mediat. 2013, 107, 95–102. DOI: https://doi.org/10.1016/j.prostaglandins.2013.04.003
Roberts LJ. Montine TJ. Markesbery WR. Tapper AR. Hardy P. Chemtob S. Dettbarn WD. Morrow JD. J. Biol. Chem. 1998, 273, 13605–13612. DOI: https://doi.org/10.1074/jbc.273.22.13605
Fessel JP. Porter NA. Moore KP. Sheller JR. Roberts LJ. Proc. Natl. Acad. Sci. 2002, 99, 16713–16718. DOI: https://doi.org/10.1073/pnas.252649099
Taber DF. Fessel JP. Roberts II LJ. Prostaglandins Other Lipid Mediat. 2004, 73, 47–50. DOI: https://doi.org/10.1016/j.prostaglandins.2003.11.004
Song WL. Lawson JA. Reilly D. Rokach J. Chang CT. Giasson B. FitzGerald GA. J. Biol. Chem. 2008, 283, 6–16. DOI: https://doi.org/10.1074/jbc.M706124200
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.